12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  

12/2/2024Nanjing Leads Biolabs Files for Hong Kong IPO

12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...

12/2/2024Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...

12/2/2024Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...

12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...

12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia

12/2/2024Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange

12/2/2024Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...

12/2/2024UCB Closes Divestment from Neurology and Allergy Portfolio in China, ...

11/29/2024Recent Executive Moves

11/28/2024NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs

11/28/2024NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List

11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...

11/28/2024BeOne Secures EU Approval for First-Line Checkpoint Blocker

11/28/2024AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...

11/27/2024ChP Commission Approves Chinese Pharmacopeia 2025

11/27/2024Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...

11/27/2024Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug

11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...

11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China

11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China

11/27/2024NHSA: Policies in Development to Synchronize Medical Insurance Funds a...

11/27/2024China Introduces New Policy to Strengthen Hierarchical Medical Care an...

11/27/2024Asian Market Rattled by Trump Tariffs: Yang Report (LinkedIn)

11/26/2024Rise In Clinical Trial Activity Will Support Hong Kong, China’s Pharm...

11/26/2024Snapshot of BMI System Financial Performance in 3Qs/2024

11/25/2024Kanglin Biotech Announces $20M Series A Financing to Advance Gene Ther...

11/25/2024Hanx Biopharma Submits IPO Application to HKSE

11/25/2024Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...

Page:36/774 Total number of articles:23208: [First][<<] [34] [35] [36] [37] [38] [>>] [End]